CHOP versus PMItCEBO with/without G-CSF in patients aged sixty years plus with non-hodgkin's lymphoma

Phase 3

Completed

• Conditions: Cancer; on-Hodgkin's lymphoma; Non-Hodgkin's lymphoma

• Registration Number: ISRCTN98741793
• Lead Sponsor: ymphoma Research Trust (UK)

Brief Summary

2009 results in http://www.ncbi.nlm.nih.gov/pubmed/19450285

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2002-08-19
• Study Completion: 2004-04-20
• Last Update Posted: 19 November 2018

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 880

Inclusion Criteria

1. Aged at least 60 years
2. Newly presenting aggressive non-Hodgkin's lymphoma
3. Bulky stage IA and stages IB - IV
4. Patients must be free from any other irreversible medical condition that would drastically limit their life span or prohibit the use of combination chemotherapy
5. Adequate renal, hepatic and cardiac function
6. No previous malignancy
7. No central nervous system (CNS) involvement with non-Hodgkin's lymphoma

Exclusion Criteria

Patients with lymphoblastic and Burkitt's lymphoma

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Failure free survival

Secondary Outcome Measures

Name	Time	Method
ot provided at time of registration